Tonix Pharmaceuticals to Present at Two Major Investor Conferences in 2026
August 5, 2026 — Tonix Pharmaceuticals to present at Canaccord and Morgan Stanley conferences in 2026. CEO Seth Lederman to discuss CNS and immunology pipeline, including TONMYA for fibromyalgia.